bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Sept. 28, 2023
ABSTRACT
Antigenic
drift
of
SARS-CoV-2
is
typically
defined
by
mutations
in
the
N-terminal
domain
and
receptor
binding
spike
protein.
In
contrast,
whether
antigenic
occurs
S2
remains
largely
elusive.
Here,
we
perform
a
deep
mutational
scanning
experiment
to
identify
that
affect
three
apex
public
antibodies.
Our
results
indicate
spatially
diverse
mutations,
including
D950N
Q954H,
which
are
observed
Delta
Omicron
variants,
respectively,
weaken
these
Although
antibodies
known
be
non-neutralizing,
show
they
confer
partial
protection
vivo
.
We
further
demonstrate
such
activity
diminished
natural
mutation
D950N.
Overall,
this
study
indicates
can
undergo
drift,
represents
potential
challenge
for
development
more
universal
coronavirus
vaccines.
Current Opinion in Virology,
Journal Year:
2023,
Volume and Issue:
62, P. 101349 - 101349
Published: Aug. 28, 2023
SARS
coronavirus
2
(SARS-CoV-2),
the
causative
agent
of
COVID-19,
emerged
in
China
December
2019.
Vaccines
developed
were
very
effective
initially,
however,
virus
has
shown
remarkable
evolution
with
multiple
variants
spreading
globally
over
last
three
years.
Nowadays,
newly
emerging
Omicron
lineages
are
gaining
substitutions
at
a
fast
rate,
resulting
escape
from
neutralization
by
antibodies
that
target
Spike
protein.
Tools
to
map
impact
on
further
antigenic
SARS-CoV-2,
such
as
cartography,
may
be
helpful
update
SARS-CoV-2
vaccines.
In
this
review,
we
focus
highlighting
protein
individually
and
combination
immune
escape.
Proceedings of the National Academy of Sciences,
Journal Year:
2024,
Volume and Issue:
121(15)
Published: April 1, 2024
Antigenic
drift
of
SARS-CoV-2
is
typically
defined
by
mutations
in
the
N-terminal
domain
and
receptor
binding
spike
protein.
In
contrast,
whether
antigenic
occurs
S2
remains
largely
elusive.
Here,
we
perform
a
deep
mutational
scanning
experiment
to
identify
that
affect
three
apex
public
antibodies.
Our
results
indicate
spatially
diverse
mutations,
including
D950N
Q954H,
which
are
observed
Delta
Omicron
variants,
respectively,
weaken
these
Although
antibodies
known
be
nonneutralizing,
show
they
confer
protection
vivo
through
Fc-mediated
effector
functions.
Overall,
this
study
indicates
can
undergo
drift,
represents
potential
challenge
for
development
more
universal
coronavirus
vaccines.
BMC Infectious Diseases,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: March 13, 2025
Prolonged
SARS-CoV-2
infection
observed
in
immunocompromised
individuals
even
the
presence
of
antiviral
treatment
provides
opportunities
for
viruses
to
evolve
immune
escape
and
drug-resistant
variants.
A
72-year-old
male
with
IgG4-related
disease
was
admitted
Emergency
Department
a
city
Hospital
Milan
then
transferred
Fondazione
IRCCS
Ca'
Granda
Ospedale
Maggiore
Policlinico
December
2023,
due
respiratory
distress
diagnosed
November
2023.
After
117
days
since
onset
infection,
two
cycles
sotrovimab/remdesivir
combined
therapy,
clinical
improvement
allowed
hospital
discharge,
notwithstanding
persistent
positivity.
Fifteen
later,
patient
re-admitted
worsening
conditions.
third
cycle
therapy
prolonged
nirmatrelvir/ritonavir,
nasopharyngeal
load
dropped
conditions
improved,
ending
successful
discharge.
whole
genome
sequences,
obtained
at
six
time-points
showed
an
FL.1.5.1
recombinant
form
genetic
distance
median
(IQR)
0.00052
(0.00041–0.00066)
similar
among
43
contemporaneous
forms
(p
=
0.098).
De
novo
SNPs
were
all
time
points,
peak
(n
70)
day
133
corresponding
second
hospitalization.
Six
non-synonymous
mutations
(three
RdRp
three
spike
protein,
four
them
known
be
associated
drug
resistance)
appeared
transiently,
after
fourth
course
sotrovimab
500
mg/remdesivir
combination.
Five
de
SNPs,
fixed
over
long-lasting
infection.
The
N856K,
reduced
fusogenicity
infectivity
Omicron
BA.1,
completely
replaced
by
constitutive
N
136.
This
case
confirms
intra-host
evolution
dynamics
immunocompromised,
prolonged-infected
individual,
involving
positions
resistance
fusogenic
traits
SARS-CoV-2.
These
results
underscore
importance
early
detection
individuals,
its
rapid
containment
using
highly
effective
treatment,
limit
serious
complications
risk
new
potentially
concerning
viral
variants
emergence.
Frontiers in Molecular Biosciences,
Journal Year:
2023,
Volume and Issue:
10
Published: Nov. 2, 2023
Coronavirus
disease
2019
(COVID-19),
caused
by
the
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
is
a
major
global
health
concern
associated
with
millions
of
fatalities
worldwide.
Mutant
variants
virus
have
further
exacerbated
COVID-19
mortality
and
infection
rates,
emphasizing
urgent
need
for
effective
preventive
strategies.
Understanding
viral
mechanism
crucial
developing
therapeutics
vaccines.
The
entry
SARS-CoV-2
into
host
cells
key
step
in
pathway
has
been
targeted
drug
development.
Despite
numerous
reviews
virus,
there
lack
comprehensive
focusing
on
structural
aspects
entry.
In
this
review,
we
analyze
changes
Spike
proteins
during
process,
dividing
process
prebinding,
receptor
binding,
proteolytic
cleavage,
membrane
fusion
steps.
By
understanding
atomic-scale
details
entry,
can
better
target
intervention
We
also
examine
impacts
mutations
proteins,
including
Omicron
variant,
Structural
information
provides
insights
effects
guide
development
Finally,
discuss
available
structure-based
approaches
Overall,
review
detailed
analysis
highlighting
its
significance
vaccines
against
COVID-19.
Therefore,
our
emphasizes
importance
combating
infection.
Cells,
Journal Year:
2024,
Volume and Issue:
13(3), P. 203 - 203
Published: Jan. 23, 2024
Severe
acute
respiratory
syndrome
coronavirus
type
2
(SARS-CoV-2)
utilizes
angiotensin-converting
enzyme
(ACE2)
as
its
main
receptor
for
cell
entry.
We
bioengineered
a
soluble
ACE2
protein
termed
618-DDC-ABD
that
has
increased
binding
to
SARS-CoV-2
and
prolonged
duration
of
action.
Here,
we
investigated
the
protective
effect
this
when
administered
intranasally
k18-hACE2
mice
infected
with
aggressive
Delta
variant.
were
variant
by
inoculation
lethal
dose
(2
×
104
PFU).
(10
mg/kg)
or
PBS
was
six
hours
prior
24
48
h
post-viral
inoculation.
All
animals
in
control
group
succumbed
disease
on
day
seven
post-infection
(0%
survival),
whereas,
contrast,
there
only
one
casualty
received
(90%
survival).
Mice
had
minimal
assessed
using
clinical
score
stable
weight,
both
brain
lung
viral
titers
markedly
reduced.
These
findings
demonstrate
efficacy
decoy
an
extended
action
protecting
against
Together
previous
work,
these
underline
universal
potential
current
future
emerging
variants.
Journal of Virology,
Journal Year:
2023,
Volume and Issue:
98(1)
Published: Dec. 13, 2023
SARS-CoV-2
variants
with
undetermined
properties
have
emerged
intermittently
throughout
the
COVID-19
pandemic.
Some
possess
unique
phenotypes
and
mutations
which
allow
further
characterization
of
viral
evolution
Spike
functions.
Around
1,100
cases
B.1.640.1
variant
were
reported
in
Africa
Europe
between
2021
2022,
before
expansion
Omicron.
Here,
we
analyzed
biological
a
isolate
its
Spike.
Compared
to
ancestral
Spike,
carried
14
amino
acid
substitutions
deletions.
escaped
binding
by
some
anti-N-terminal
domain
anti-receptor-binding
monoclonal
antibodies,
neutralization
sera
from
convalescent
vaccinated
individuals.
In
cell
lines,
infection
generated
large
syncytia
high
cytopathic
effect.
primary
airway
cells,
replicated
less
than
Omicron
BA.1
triggered
more
death
other
variants.
The
was
highly
fusogenic
when
expressed
alone.
This
mediated
two
poorly
characterized
infrequent
located
S2
domain,
T859N
D936H.
Altogether,
our
results
highlight
cytopathy
hyper-fusogenic
variant,
supplanted
upon
emergence
BA.1.
(This
study
has
been
registered
at
ClinicalTrials.gov
under
registration
no.
NCT04750720.)IMPORTANCEOur
plasticity
generate
strains
causative
being
uncharacterized
previous
We
describe
mechanisms
regulating
formation
subsequent
consequences
culture
model,
are
understood.
Frontiers in Immunology,
Journal Year:
2023,
Volume and Issue:
14
Published: Sept. 27, 2023
In
November
2021,
the
SARS-CoV-2
Omicron
variant
of
concern
has
emerged
and
is
currently
dominating
COVID-19
pandemic
over
world.
displays
a
number
mutations,
particularly
in
spike
protein,
leading
to
specific
characteristics
including
higher
potential
for
transmission.
Although
caused
significant
deaths
worldwide,
it
generally
induces
less
severe
clinical
signs
compared
earlier
variants.
As
its
impact
on
blood
platelets
remains
unknown,
we
investigated
platelet
behavior
patients
infected
with
comparison
Delta.
Clinical
biological
(n=9)
or
Delta
(n=11)
variants
were
analyzed.
Using
complementary
methods
such
as
flow
cytometry,
confocal
imaging
electron
microscopy,
examined
activation,
responsiveness
phenotype,
presence
virus
induction
selective
autophagy.
We
also
explored
direct
effect
proteins
from
healthy
signaling.
Severe
infection
resulted
activation
partial
desensitization,
autophagy
response.
The
intraplatelet
processing
viral
cargo
was
different
evidenced
by
distribution
protein-positive
structures
near
plasma
membrane
colocalization
Rab7.
Moreover,
alone
activated
signaling
pathways
phosphorylation
AKT,
p38MAPK,
LIMK
SPL76
kinetics.
prior
variants,
leads
desensitization
previously
observed
variant.
found
where
autophagy,
but
mechanisms
cargo,
part
innate
response,
differs
Delta,
suggesting
that
mutations
protein
modify
interactions.
Frontiers in Medicine,
Journal Year:
2024,
Volume and Issue:
11
Published: Aug. 29, 2024
Since
the
SARS-CoV-2
outbreak
in
2019,
a
diversity
of
viral
genomic
variants
has
emerged
and
spread
globally
due
to
increased
transmissibility,
pathogenicity,
immune
evasion.
By
first
trimester
2023
Chile,
as
most
countries,
BQ
XBB
were
predominant
circulating
sub-lineages
Omicron.
The
molecular
antigenic
characteristics
these
have
been
mainly
determined
using
non-authentic
spike
pseudoviruses,
which
is
often
described
limitation.
Additionally,
few
comparative
studies
isolates
from
recent
Omicron
conducted.
In
this
study,
we
isolated
clinical
samples,
including
ancestral
B.1.1,
Delta,
BA.1,
BA.2
BA.5.
We
assessed
their
infectivity
through
cell
culture
infections
antibody
evasion
neutralization
assays.
observed
variations
plaque
size,
morphology,
cytotoxicity
upon
infection
Vero
E6-TMPRSS2
cells
for
each
variant
compared
B.1.1
virus.
BA.2-derived
sub-variants,
such
XBB.1.5,
showed
attenuated
replication,
while
BA.5-derived
variants,
BQ.1.1,
exhibited
replication
rates
similar
Similar
trends
intestinal
Caco-2
cells,
except
Delta.
Antibody
experiments
sera
individuals
infected
during
COVID-19
wave
(FWI)
consistent
but
moderate
reduction
against
sub-lineages.
Interestingly,
despite
being
less
prevalent,
BQ.1.1
6.1-fold
greater
escape
than
XBB.1.5.
Neutralization
patterns
when
tested
vaccinated
with
3xBNT162b2
(PPP)
or
Coronavac-Coronavac-BNT162b2
(CCP)
schedules.
However,
CCP
2.3-fold
higher
XBB.1.5
FWI
PPP
sera.
This
study
provides
new
insights
into
differences
between
leading
eventual
outcompetition.
Our
analysis
offers
important
evidence
regarding
balance
that
drives
evolution
second-generation
population.
Computational and Structural Biotechnology Journal,
Journal Year:
2024,
Volume and Issue:
23, P. 2407 - 2417
Published: May 24, 2024
The
continuous
evolution
of
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
which
caused
the
recent
pandemic,
has
generated
countless
new
variants
with
varying
fitness.
Mutations
spike
glycoprotein
play
a
particularly
vital
role
in
shaping
its
evolutionary
trajectory,
as
they
have
capability
to
alter
infectivity
and
antigenicity.
We
present
time-resolved
statistical
method,
Dynamic
Expedition
Leading
(deLemus),
analyze
dynamics
SARS-CoV-2
glycoprotein.
proposed
Journal of Advanced Research in Micro and Nano Engieering,
Journal Year:
2024,
Volume and Issue:
21(1), P. 54 - 65
Published: July 31, 2024
SARS-CoV-2
virus
undergoes
mutation,
leading
to
the
virus's
evolution
and
modifications
in
characteristics
of
virus.
Omicron,
including
BA.2
subvariant,
is
currently
predominant
variant
infection.
There
are
no
reports
regarding
its
properties
or
utilization
Indonesian
isolate
for
therapy
vaccine
development.
Therefore,
this
study
evaluated
appropriate
host
cells
Omicron
via
susceptibility
tests.
The
from
Indonesia
was
exposed
three
mammalian-ACE2-expressing
cell
lines.
Sharing
amino
acids
between
previous
VOC
subvariants
performed
using
a
simple
silico
comparison
method.
results
showed
that
could
not
infect
HepG2
Huh-7D12
due
foci
forming
on
those
Moreover,
we
also
found
has
unique
acid
alteration
spike
protein.
According
findings,
propagate
Vero
E6
lines,
mutations
play
role
changing
infection
mechanism.
A
deeper
vitro
experiment
enhance
findings
by
comparing
all
sequences
analyzing
mechanism
each
single
mutation
pseudovirus.